Replies to post #60650 on Biotech Values

[DewDiligence]

MNTA – A formal response to the FDA’s generic-Lovenox concerns will be submitted in early May 2008.

Source: http://www.novartis.com/downloads/investors/sales-results/Q1-2008-IR-slides.pdf [page #27, top]